Dror Limon

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors

Deborah T. Blumenthal, Michal Yalon, Gilad W. Vainer et al. · Journal of Neuro-Oncology · 2016 · 100 citations

Neuro-oncology, Tumoral Pathology, Tumor Innervation +7

Delayed contrast extravasation MRI: a new paradigm in neuro-oncology

Leor Zach, David Guez, David Last et al. · Neuro-Oncology · 2014 · 95 citations · Full text

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

Jair Bar, Nir Peled, Shiruyeh Schokrpur et al. · Journal of Thoracic Oncology · 2022 · 92 citations · Full text

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study

Felix Bokstein, Deborah T. Blumenthal, Dror Limon et al. · Frontiers in Oncology · 2020 · 65 citations · Full text